Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005634 | nucleus | 5 | 3 |
GO:0043226 | organelle | 2 | 3 |
GO:0043227 | membrane-bounded organelle | 3 | 3 |
GO:0043229 | intracellular organelle | 3 | 3 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 3 |
GO:0110165 | cellular anatomical entity | 1 | 3 |
Related structures:
AlphaFold database: A4HH71
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 11 |
GO:0006259 | DNA metabolic process | 4 | 11 |
GO:0006281 | DNA repair | 5 | 11 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 11 |
GO:0006807 | nitrogen compound metabolic process | 2 | 11 |
GO:0006950 | response to stress | 2 | 11 |
GO:0006974 | DNA damage response | 4 | 11 |
GO:0008152 | metabolic process | 1 | 11 |
GO:0009987 | cellular process | 1 | 11 |
GO:0033554 | cellular response to stress | 3 | 11 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 11 |
GO:0043170 | macromolecule metabolic process | 3 | 11 |
GO:0044237 | cellular metabolic process | 2 | 11 |
GO:0044238 | primary metabolic process | 2 | 11 |
GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 11 |
GO:0046483 | heterocycle metabolic process | 3 | 11 |
GO:0050896 | response to stimulus | 1 | 11 |
GO:0051716 | cellular response to stimulus | 2 | 11 |
GO:0071704 | organic substance metabolic process | 2 | 11 |
GO:0090304 | nucleic acid metabolic process | 4 | 11 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 11 |
GO:0003677 | DNA binding | 4 | 11 |
GO:0003824 | catalytic activity | 1 | 11 |
GO:0004518 | nuclease activity | 4 | 11 |
GO:0004527 | exonuclease activity | 5 | 11 |
GO:0004529 | DNA exonuclease activity | 5 | 11 |
GO:0004536 | DNA nuclease activity | 4 | 11 |
GO:0005488 | binding | 1 | 11 |
GO:0008409 | 5'-3' exonuclease activity | 6 | 11 |
GO:0016787 | hydrolase activity | 2 | 11 |
GO:0016788 | hydrolase activity, acting on ester bonds | 3 | 11 |
GO:0016796 | exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 6 | 11 |
GO:0016895 | DNA exonuclease activity, producing 5'-phosphomonoesters | 6 | 11 |
GO:0033699 | DNA 5'-adenosine monophosphate hydrolase activity | 8 | 11 |
GO:0035312 | 5'-3' DNA exonuclease activity | 7 | 11 |
GO:0097159 | organic cyclic compound binding | 2 | 11 |
GO:0140097 | catalytic activity, acting on DNA | 3 | 11 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 11 |
GO:1901363 | heterocyclic compound binding | 2 | 11 |
GO:0043167 | ion binding | 2 | 3 |
GO:0043169 | cation binding | 3 | 3 |
GO:0046872 | metal ion binding | 4 | 3 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 13 | 15 | PF00675 | 0.584 |
CLV_NRD_NRD_1 | 157 | 159 | PF00675 | 0.303 |
CLV_PCSK_KEX2_1 | 13 | 15 | PF00082 | 0.637 |
CLV_PCSK_KEX2_1 | 157 | 159 | PF00082 | 0.303 |
CLV_PCSK_SKI1_1 | 144 | 148 | PF00082 | 0.269 |
DEG_APCC_DBOX_1 | 24 | 32 | PF00400 | 0.374 |
DEG_Nend_UBRbox_3 | 1 | 3 | PF02207 | 0.649 |
DEG_SPOP_SBC_1 | 50 | 54 | PF00917 | 0.605 |
DOC_CDC14_PxL_1 | 163 | 171 | PF14671 | 0.399 |
DOC_CDC14_PxL_1 | 69 | 77 | PF14671 | 0.384 |
DOC_CYCLIN_yCln2_LP_2 | 110 | 116 | PF00134 | 0.423 |
DOC_MAPK_gen_1 | 25 | 34 | PF00069 | 0.464 |
DOC_MAPK_RevD_3 | 174 | 190 | PF00069 | 0.365 |
DOC_PP2B_LxvP_1 | 110 | 113 | PF13499 | 0.399 |
DOC_USP7_MATH_1 | 16 | 20 | PF00917 | 0.474 |
DOC_USP7_MATH_1 | 165 | 169 | PF00917 | 0.423 |
DOC_USP7_MATH_1 | 38 | 42 | PF00917 | 0.511 |
DOC_USP7_MATH_1 | 50 | 54 | PF00917 | 0.575 |
DOC_USP7_MATH_1 | 83 | 87 | PF00917 | 0.326 |
DOC_USP7_UBL2_3 | 249 | 253 | PF12436 | 0.266 |
DOC_USP7_UBL2_3 | 36 | 40 | PF12436 | 0.480 |
DOC_WW_Pin1_4 | 180 | 185 | PF00397 | 0.421 |
DOC_WW_Pin1_4 | 46 | 51 | PF00397 | 0.623 |
LIG_14-3-3_CanoR_1 | 117 | 122 | PF00244 | 0.500 |
LIG_14-3-3_CanoR_1 | 144 | 154 | PF00244 | 0.513 |
LIG_14-3-3_CanoR_1 | 215 | 219 | PF00244 | 0.294 |
LIG_Actin_WH2_2 | 131 | 149 | PF00022 | 0.503 |
LIG_BIR_III_2 | 100 | 104 | PF00653 | 0.399 |
LIG_CtBP_PxDLS_1 | 113 | 117 | PF00389 | 0.423 |
LIG_DLG_GKlike_1 | 117 | 124 | PF00625 | 0.503 |
LIG_FHA_1 | 1 | 7 | PF00498 | 0.435 |
LIG_LIR_Gen_1 | 194 | 201 | PF02991 | 0.378 |
LIG_LIR_Nem_3 | 140 | 145 | PF02991 | 0.424 |
LIG_LIR_Nem_3 | 194 | 198 | PF02991 | 0.342 |
LIG_LYPXL_yS_3 | 72 | 75 | PF13949 | 0.365 |
LIG_PAM2_1 | 60 | 72 | PF00658 | 0.270 |
LIG_Pex14_2 | 159 | 163 | PF04695 | 0.432 |
LIG_Pex14_2 | 195 | 199 | PF04695 | 0.233 |
LIG_PTB_Apo_2 | 96 | 103 | PF02174 | 0.399 |
LIG_SH2_STAT5 | 137 | 140 | PF00017 | 0.403 |
LIG_SH2_STAT5 | 142 | 145 | PF00017 | 0.395 |
LIG_SH3_1 | 70 | 76 | PF00018 | 0.249 |
LIG_SH3_3 | 164 | 170 | PF00018 | 0.399 |
LIG_SH3_3 | 70 | 76 | PF00018 | 0.249 |
LIG_TRFH_1 | 72 | 76 | PF08558 | 0.364 |
LIG_WRC_WIRS_1 | 192 | 197 | PF05994 | 0.254 |
LIG_WRPW_2 | 69 | 72 | PF00400 | 0.400 |
MOD_CDK_SPxxK_3 | 180 | 187 | PF00069 | 0.424 |
MOD_CK1_1 | 19 | 25 | PF00069 | 0.428 |
MOD_CK1_1 | 194 | 200 | PF00069 | 0.247 |
MOD_CK1_1 | 41 | 47 | PF00069 | 0.438 |
MOD_CK1_1 | 53 | 59 | PF00069 | 0.611 |
MOD_CK1_1 | 77 | 83 | PF00069 | 0.535 |
MOD_CK2_1 | 55 | 61 | PF00069 | 0.643 |
MOD_GlcNHglycan | 18 | 21 | PF01048 | 0.315 |
MOD_GlcNHglycan | 3 | 6 | PF01048 | 0.549 |
MOD_GlcNHglycan | 40 | 43 | PF01048 | 0.450 |
MOD_GlcNHglycan | 55 | 58 | PF01048 | 0.536 |
MOD_GlcNHglycan | 76 | 79 | PF01048 | 0.420 |
MOD_GSK3_1 | 1 | 8 | PF00069 | 0.594 |
MOD_GSK3_1 | 12 | 19 | PF00069 | 0.528 |
MOD_GSK3_1 | 146 | 153 | PF00069 | 0.415 |
MOD_GSK3_1 | 247 | 254 | PF00069 | 0.250 |
MOD_GSK3_1 | 38 | 45 | PF00069 | 0.455 |
MOD_GSK3_1 | 46 | 53 | PF00069 | 0.574 |
MOD_GSK3_1 | 56 | 63 | PF00069 | 0.593 |
MOD_N-GLC_1 | 42 | 47 | PF02516 | 0.313 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.482 |
MOD_NEK2_1 | 146 | 151 | PF00069 | 0.458 |
MOD_PKA_2 | 12 | 18 | PF00069 | 0.558 |
MOD_PKA_2 | 214 | 220 | PF00069 | 0.294 |
MOD_Plk_4 | 102 | 108 | PF00069 | 0.399 |
MOD_Plk_4 | 194 | 200 | PF00069 | 0.344 |
MOD_Plk_4 | 60 | 66 | PF00069 | 0.306 |
MOD_Plk_4 | 84 | 90 | PF00069 | 0.344 |
MOD_ProDKin_1 | 180 | 186 | PF00069 | 0.421 |
MOD_ProDKin_1 | 46 | 52 | PF00069 | 0.626 |
MOD_SUMO_rev_2 | 77 | 83 | PF00179 | 0.417 |
TRG_DiLeu_BaLyEn_6 | 127 | 132 | PF01217 | 0.441 |
TRG_DiLeu_BaLyEn_6 | 70 | 75 | PF01217 | 0.463 |
TRG_ENDOCYTIC_2 | 192 | 195 | PF00928 | 0.246 |
TRG_ENDOCYTIC_2 | 72 | 75 | PF00928 | 0.365 |
TRG_ER_diArg_1 | 12 | 14 | PF00400 | 0.617 |
TRG_ER_diArg_1 | 157 | 159 | PF00400 | 0.503 |
TRG_Pf-PMV_PEXEL_1 | 205 | 209 | PF00026 | 0.294 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IB39 | Leptomonas seymouri | 68% | 100% |
A0A0S4IR98 | Bodo saltans | 40% | 100% |
A0A0S4JC46 | Bodo saltans | 30% | 85% |
A0A0S4JGA0 | Bodo saltans | 39% | 100% |
A0A1X0NZZ4 | Trypanosomatidae | 50% | 100% |
A0A3S7X266 | Leishmania donovani | 84% | 100% |
A4I4B7 | Leishmania infantum | 84% | 100% |
C9ZL51 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 45% | 100% |
E9AM14 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 83% | 100% |
O74859 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 29% | 100% |
P61798 | Gallus gallus | 34% | 84% |
Q08702 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 26% | 100% |
V5BUM6 | Trypanosoma cruzi | 50% | 100% |